India to Iraq: Regorafenib Export Trade Route

The India to Iraq Regorafenib corridor is one of India's established pharmaceutical export routes, with 15 shipments documented worth a combined $18.6K USD. The route is dominated by RMPL PHARMA LLP, which alone accounts for roughly 39% of all export value, reflecting the consolidated nature of India's regorafenib manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $1.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with regorafenib's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 11.3%, placing it at rank #10 among India's top regorafenib export destinations globally.

On the import side, key buyers of Indian regorafenib in Iraq include NA, SKIN LINE LOGISTIC, ZMC EXPRESS CARGO FZCO and 2 others. NA is the single largest importer with 1 shipments valued at $7.3K USD.

India's regorafenib exports to Iraq are driven primarily by a handful of large-scale manufacturers. RMPL PHARMA LLP with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Iraq benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — RMPL PHARMA LLP, SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED, RAVI PHARMA — together account for 89% of total trade value on this route. The average shipment value of $1.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as regonat 40mg tab.regorafenib tablets 40mg (1*28 tab.) as per invoice and regonat tab.regorafenib tablets 40mg1*28 tab. as per document , suggesting that buyers in Iraq tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 1 shipments worth $7.3K USD — representing 39% of all regorafenib imports from India on this route.